2- October-2023- News Agencies
Ururka Caafimaadka Adduunka (WHO) ayaa ku taliyay tallaalka duumada labaad, go’aankaas oo siin kara waddammada dookh ka jaban oo diyaarsan oo la heli karo marka loo eego tallaalka ugu horreeya adduunka ee cudurka dulin.
R21/Matrix-M, oo ay soo saartay jaamacadda Oxford ee Britain, ayaa loo isticmaali karaa in lagu xakameeyo cudurka nafta halis gelinaya ee ay ku faafiso dadka kaneecada qaarkeed, WHO ayaa sidaas sheegtay Isniintii.
Agaasimaha guud ee WHO Tedros Adhanom Ghebreyesus ayaa sheegay in hay’adda caafimaadka ee Qaramada Midoobay ay ansixinayso tallaalka cusub ee duumada iyadoo la tixraacayo talada laba kooxood oo khubaro ah, isagoo ku taliyay in loo isticmaalo carruurta halista ugu jirta cudurka.
“Cilmi-baare kaneeco ahaan, waxaan ku riyoon jiray maalinta aan heli doono tallaal badbaado leh oo waxtar leh oo ka hortagga duumada. Hadda waxaan haynaa labo,” ayuu yiri Tedros.
Tallaalka R21/Matrix-M waxaa soo saaray machadka Serum Institute of India waxaana horay loogu oggolaaday in lagu isticmaalo Burkina Faso, Ghana iyo Nigeria.
Tedros ayaa sheegay in tallaalka laga bilaabi doono dalalkaas Afrika horraanta sanadka 2024-ka, waxaana laga heli doonaa bartamaha sannadka 2024-ka waddamo kale, ayuu yiri Tedros, isagoo intaas ku daray in qiyaasaha ay ku kacayaan ay ku kici doonaan $2 illaa $4.
“WHO ayaa hadda dib u eegis ku samaynaysa tallaalka si ay ugu qalanto, taas oo ah shaambada oggolaanshaha ee WHO, waxayna awood u siin doontaa GAVI [isbahaysiga tallaalka caalamiga ah] iyo UNICEF inay ka iibsadaan tallaalka soo saarayaasha,” Tedros ayaa yiri
Jaamacadda Oxford waxay soo saartay tallaalka cusub ee saddexda qiyaas ah iyadoo ay gacan ka geysatay Machadka Serum Institute of India.
Cilmi-baaristu waxay soo jeedisay inay ka badan tahay 75 boqolkiiba waxtarka iyo ilaalinta waxaa lagu hayaa ugu yaraan sanad kale iyada oo la xoojinayo
Labada tallaal ee duumada midkoodna, si kastaba ha ahaatee, ma joojiyaan gudbinta, sidaa dartee壯陽藥 d ololayaasha tallaalka oo keliya kuma filna in ay joojiyaan cudurrada faafa.
Dadaallada lagu xakameynayo cudurka ayaa sidoo kale ah mid adag iyadoo la kordhinayo warbixinnada ku saabsan caabbinta daawooyinka ugu muhiimsan ee loo isticmaalo daawaynta duumada iyo faafidda noocyada kaneecada.
Tedros wuxuu sheegay in WHO ay sidoo kale kula talisay Takeda Pharmaceuticals tallaalka dengue ee carruurta da’doodu u dhaxayso lix ilaa 16 ee ku nool meelaha uu cudurku ku yahay dhibaato caafimaad oo weyn.
Dengue, oo ku badan cimilo kulaylaha iyo kulaylaha hoose, waa caabuq fayras ah oo ay kaneecada u gudbiso dadka.
Tallaalka Takeda, oo loo yaqaan Qdenga, ayaa lagu muujiyay tijaabooyinka si uu waxtar ugu yeesho dhammaan afarta nooc ee fayraska ee dadka horay ugu dhacay cudurka dengue, Hanna Nohynek, oo ah guddoomiyaha kooxda la-talinta istaraatiijiyadeed ee WHO ee khubarada talaalka, ayaa u sheegtay suxufiyiinta.
Waxay ku dartay, si kastaba ha ahaatee, in ay jirto hubaal la’aan ku saabsan waxqabadkeeda serotypes 3 iyo 4 ee dadka aan hore u qaadin cudurka.
